Cargando…

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL

Detalles Bibliográficos
Autores principales: Achebe, M, Nduba, V, Hassab, H, Alkindi, S, Brown, R, Telfer, P, Biemond, B, Gordeuk, V, Lipato, T, Tonda, M, Gray, S, Howard, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812111/
http://dx.doi.org/10.1097/01.HS9.0000821440.09294.d3